Literature DB >> 30190762

Prevalence of Migraine among patients of Depressive Disorder.

Muhammad Ilyas Jat1, Muhammad Iqbal Afridi2, Washdev Amar3, Chooni Lal4.   

Abstract

OBJECTIVE: To find out the prevalence of Migraine among patients of Depressive Disorder.
METHODS: A descriptive cross sectional study, conducted at Department of Psychiatry and Behavioral Sciences, JPMC, Karachi from 1st January 2014 to 30th June 2014. Total 272 patients were enrolled in the study. Depressive disorder was diagnosed as per ICD-10 criteria and Migraine headache as ICHD-2 criteria for diagnosis.
RESULTS: A total of 272 patients with mean age of 31.85 ± 8.7 were enrolled. Out of 272 cases 64% were females; Out of total cases 86.4% were married. Migraine with aura was seen among 6.6% and migraine without aura was present among 26.1%. Migraine was linked more with females and married and of those having severe Depressive disorder.
CONCLUSION: Migraine headache is common among depressed people, particularly females and having severe depression, so it ought to be remembered that while looking for Depressive disorder or headache the other condition must be remembered.

Entities:  

Keywords:  Depressive disorder; Migraine; Prevalence

Year:  2018        PMID: 30190762      PMCID: PMC6115550          DOI: 10.12669/pjms.344.14693

Source DB:  PubMed          Journal:  Pak J Med Sci        ISSN: 1681-715X            Impact factor:   1.088


INTRODUCTION

Depression/Depressive disorder is a mood disorder, characterized by low mood, lack of interest and enjoyment, reduced self-esteem, slowness and reduced energy, disturbed sleep and appetite, leading to decreased social and occupational functioning. Life time prevalence of Depressive disorder is 18 to 22% and one year rate is 2-5% having greater ratio in females than males.1 Migraine is a chronic neurological headache disorder accompanied with some autonomic nervous symptoms such as nausea, vomiting, photophobia (sensitivity to light) and phonophobia (sensitivity to sound). The International Classification of Headache Disorders (ICHD) published by the International Headache Society (IHS)2 is used as the most reliable and acceptable diagnostic criteria for migraine. According to the IHS criteria, previous studies consistently showed a lifetime prevalence of migraine at 10–20%.3 Both migraine and depression are common complex diseases with complicated inheritance patterns, episodic manifestations and great burdens on general populations.4 The increased chances of having depression while suffering from migraine is an example of an association known in epidemiological jargon as “bi-directional co-morbidity”.5 It is pertinent to note that the classification of migraine can be divided into six major types of which the “migraine with aura” sub-type has the highest association with the risk of developing depression.6 The bi-directional relationship between these two disease entities has been scrutinized and confirmed by in-depth and contemporary studies.7-10 The above mentioned studies highlight a need to further explore this strong association of depression and migraine: Thus, this study is designed to reveal the burden of both illnesses simultaneously.

METHODS

This is a descriptive cross sectional type of study and was conducted at Department of Psychiatry and Behavioral Sciences, Jinnah Postgraduate Medical Centre (JPMC), Karachi, Pakistan from 1st January 2014 to 30th June 2014.The sample size of 272 cases was calculated through standard sample size calculation. Ethical considerations were taken and prior ethical approval from institute was taken, informed consent was sought from every client. Both male and females patients diagnosed with depressive disorder were enrolled. Patients, who were substance users, had Depressive Disorder due to another medical condition or due to any drug patient is taking, patients of Bipolar Depression, Post- Schizophrenic Depression or Depressive Disorder with Psychotic features were excluded from study. All depressive disorders (based on ICD-10 criteria) patients were seen for Migraine over the diagnostic criteria for migraine from International Classification of Headache Disorders second edition (ICHD-2). The data was analyzed on SPSS version 20.

RESULTS

A total of 272 patients with mean age of 31.85 ± 8.7 were enrolled. Out of 272 cases 174(64%) were females and 98(36%) were males. Out of total cases 235(86.4%) were married and 36(13.20%) were single and 1(0.4%) was widow. Out of total 86 (31.6%) were uneducated, 50(18.40%) were literate, 13(4.8%) were primary passed, 29(10.7%) were educated till middle and 34(12.5%) were matriculated and 54(19.9%) were intermediate and 6(2.2%) were graduated. Among all clients 74(27.2%) were jobless, 174(64%) were household, 13(4.8%) were students and 7(2.6%) were professionals as shown in Table-II demographic characteristics. Migraine with aura was seen among 18(6.6%) and migraine without aura was present among 71(26.1%) shown in Table-III prevalence of Migraine. Migraine was associated more with female gender and those of married and of those having severe Depressive disorder. Stratification of migraine found to be significant with gender as more common among females and with occupation as more prevalent among household workers.
Table-III

Association of Migraine with gender.

MigraineGenderTotalP-Value

MaleFemale
No Migraine88(48.1%)95(51.9%)183(100%)0.000
Migraine with aura1(5.6%)17(94.4%)18(100%)
Migraine without aura9(12.7%)62(87.3%)71(100%)

Total98(36%)174(64%)272(100%)
Frequency of Migraine. Association of Migraine with Depressive disorder. Association of Migraine with gender. Association of Migraine with Occupational and Educational Status.

DISCUSSION

Important findings of this study are that Migraine is prevalent in depressive disorder and Migraine without aura is predominant. Migraine in this study is 26.1% which is higher as compared to previous study conducted in India during 2006 and 2007, in which Migraine was found to be 12.5%.11 While in another study conducted by Naila et al found Migraine with depressive disorder was in 40% of the study patients.12 We have found out the prevalence of Migraine among depressive disorder patients as 26.1% which is quite low as compared to a study in which they observed it was 44.44%,13 selected on the basis of International Headache Society (HIS) criteria for migraine while we have used International Criteria for Headache Disorders second edition (ICHD-2) for Migraine diagnosis and in that study depression was based on 21-item HRDS for depression while we diagnosed depression as per ICD-10 criteria. In a population-based case control study, Lipton et al found that 47% of migraine patients developed depressive disorder, as compared to 17% of people who do not have migraine14; here we have seen Migraine among depressed patients rather than depression among migraine sufferers. A study conducted at Karachi, Pakistan in 2013 showed the results consistent with our results, in that research Migraine was 20.0% as compared with ours 26.1%.15 In this study, Migraine headache is more associated with female gender as evidenced in a study conducted at multiple centers across Pakistan.16 The important finding of this study is that Migraine is found more prevalent among females and those of household and this has not been looked so far. However, almost the majority of the evidence on the relationship between Migraine headache and depressive disorder is from studies on group samples or center based samples of clients having headache,17 as opposed to individuals experiencing depressive disorder. Here in our study, we have embarked to analyze the quality and specificity of the relationship amongst depressive disorder and migraine on an expansive example of individuals experiencing depressive disorder.

CONCLUSION

Migraine headache is common among peoples of depressive disorder, particularly females and having severe depression so it should to be remembered that while looking for Depressive disorder or headache the other condition ought to be remembered. Depression, when it is co-morbid with the migraine, not just increases the duration, recurrence and severity of disorder, yet in addition makes it more impervious to treatment. It likewise creates a more profound effect on personal satisfaction for the influenced individual and general expands the weight of the illness.

Author’s Contribution

MIJ: Data collection, writing of manuscript, statistical analysis. MIA: Did review and final approval of manuscript. WA: Editing of manuscript, Statistical analysis. CL: Data collection and writing of manuscript.
Table-I

Frequency of Migraine.

MigraineFrequency%
No Migraine18367.3
Migraine with aura186.6
Migraine without aura7126.1

Total272100
Table-II

Association of Migraine with Depressive disorder.

MigraineDepressive DisorderTotalP-Value

ModerateSevere
No Migraine47(25.7%)136(743%)183(100%)0.566
Migraine with aura3(16.7%)15(83.3%)18(100%)
Migraine without aura15(21.1%)56(78.9%)71(100%)

Total65(23.9%)207(76.1%)272(100%)
Table-IV

Association of Migraine with Occupational and Educational Status.

MigraineOccupationTotalP-Value

StudentHouse-holdProfessionalShopkeeperJobless
No Migraine07(3.8%)96(52.5%)06(3.3%)04(2.2%)70(38.3%)183(100%)0.000
Migraine with aura00(0%)17(94.4%)00(0%)00(0%)01(5.6%)18(100%)
Migraine without aura06(8.5%)61(85.9%)01(1.4%)00(0%)03(4.2%)71(100%)

Total13(4.8%)174(64%)07(2.6%)04(1.5%)74(27.2%)272(100%)

MigraineEducational StatusTotalP-Value

UneducatedLiteratePrimaryMiddleMatricIntermediateGraduate

No Migraine61(33.3%)28(15.3%)08(4.4%)21(11.5%)22(12.0%)38(20.8%)05(2.7%)183(100%)0.348
Migraine with aura07(38.9%)06(33.3%)02(11.1%)00(0%)00(0%)03(16.7%)00(0%)18(100%)
Migraine without aura18(25.4%)16(22.5%)03(4.2%)08(11.3%)12(16.9%)13(18.3%)01(1.4%)71(100%)

Total86(31.6%)50(18.4%)13(4.8%)29(10.7)34(12.5%)54(19.9%)06(2.2%)272(100%)
  13 in total

1.  The International Classification of Headache Disorders, 3rd edition (beta version).

Authors: 
Journal:  Cephalalgia       Date:  2013-07       Impact factor: 6.292

2.  [Chronic tension-type headache and depression].

Authors:  M Serrano-Dueñas
Journal:  Rev Neurol       Date:  2000 May 1-15       Impact factor: 0.870

3.  Use of the hospital anxiety and depression scale as a screening tool for patients with headache.

Authors:  K D Juang; S J Wang; C H Lin; J L Fuh
Journal:  Zhonghua Yi Xue Za Zhi (Taipei)       Date:  1999-11

4.  Lifetime prevalence and underdiagnosis of migraine in a population sample of Mexican women.

Authors:  C Arroyo-Quiroz; T Kurth; C Cantu-Brito; R Lopez-Ridaura; I Romieu; M Lajous
Journal:  Cephalalgia       Date:  2014-04-07       Impact factor: 6.292

5.  Psychiatric comorbidity in migraine: a review.

Authors:  F Radat; J Swendsen
Journal:  Cephalalgia       Date:  2005-03       Impact factor: 6.292

Review 6.  Migraine and its psychiatric comorbidities.

Authors:  Mia Tova Minen; Olivia Begasse De Dhaem; Ashley Kroon Van Diest; Scott Powers; Todd J Schwedt; Richard Lipton; David Silbersweig
Journal:  J Neurol Neurosurg Psychiatry       Date:  2016-01-05       Impact factor: 10.154

7.  Migraine headaches and mood/anxiety disorders in the ELSA Brazil.

Authors:  Alessandra C Goulart; Itamar S Santos; André R Brunoni; Maria Angélica Nunes; Valéria M Passos; Rosane H Griep; Paulo A Lotufo; Isabela M Benseñor
Journal:  Headache       Date:  2014-06-04       Impact factor: 5.887

8.  Comorbidities of psychiatric and headache disorders in Nepal: implications from a nationwide population-based study.

Authors:  Ajay Risal; Kedar Manandhar; Are Holen; Timothy J Steiner; Mattias Linde
Journal:  J Headache Pain       Date:  2016-04-22       Impact factor: 7.277

9.  Primary headache disorders in the adult general population of Pakistan - a cross sectional nationwide prevalence survey.

Authors:  A A Herekar; A Ahmad; U L Uqaili; B Ahmed; J Effendi; S Z Alvi; M A Shahab; U Javed; A D Herekar; Rafiq Khanani; T J Steiner
Journal:  J Headache Pain       Date:  2017-02-23       Impact factor: 7.277

10.  Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

Authors:  Theo Vos; Abraham D Flaxman; Mohsen Naghavi; Rafael Lozano; Catherine Michaud; Majid Ezzati; Kenji Shibuya; Joshua A Salomon; Safa Abdalla; Victor Aboyans; Jerry Abraham; Ilana Ackerman; Rakesh Aggarwal; Stephanie Y Ahn; Mohammed K Ali; Miriam Alvarado; H Ross Anderson; Laurie M Anderson; Kathryn G Andrews; Charles Atkinson; Larry M Baddour; Adil N Bahalim; Suzanne Barker-Collo; Lope H Barrero; David H Bartels; Maria-Gloria Basáñez; Amanda Baxter; Michelle L Bell; Emelia J Benjamin; Derrick Bennett; Eduardo Bernabé; Kavi Bhalla; Bishal Bhandari; Boris Bikbov; Aref Bin Abdulhak; Gretchen Birbeck; James A Black; Hannah Blencowe; Jed D Blore; Fiona Blyth; Ian Bolliger; Audrey Bonaventure; Soufiane Boufous; Rupert Bourne; Michel Boussinesq; Tasanee Braithwaite; Carol Brayne; Lisa Bridgett; Simon Brooker; Peter Brooks; Traolach S Brugha; Claire Bryan-Hancock; Chiara Bucello; Rachelle Buchbinder; Geoffrey Buckle; Christine M Budke; Michael Burch; Peter Burney; Roy Burstein; Bianca Calabria; Benjamin Campbell; Charles E Canter; Hélène Carabin; Jonathan Carapetis; Loreto Carmona; Claudia Cella; Fiona Charlson; Honglei Chen; Andrew Tai-Ann Cheng; David Chou; Sumeet S Chugh; Luc E Coffeng; Steven D Colan; Samantha Colquhoun; K Ellicott Colson; John Condon; Myles D Connor; Leslie T Cooper; Matthew Corriere; Monica Cortinovis; Karen Courville de Vaccaro; William Couser; Benjamin C Cowie; Michael H Criqui; Marita Cross; Kaustubh C Dabhadkar; Manu Dahiya; Nabila Dahodwala; James Damsere-Derry; Goodarz Danaei; Adrian Davis; Diego De Leo; Louisa Degenhardt; Robert Dellavalle; Allyne Delossantos; Julie Denenberg; Sarah Derrett; Don C Des Jarlais; Samath D Dharmaratne; Mukesh Dherani; Cesar Diaz-Torne; Helen Dolk; E Ray Dorsey; Tim Driscoll; Herbert Duber; Beth Ebel; Karen Edmond; Alexis Elbaz; Suad Eltahir Ali; Holly Erskine; Patricia J Erwin; Patricia Espindola; Stalin E Ewoigbokhan; Farshad Farzadfar; Valery Feigin; David T Felson; Alize Ferrari; Cleusa P Ferri; Eric M Fèvre; Mariel M Finucane; Seth Flaxman; Louise Flood; Kyle Foreman; Mohammad H Forouzanfar; Francis Gerry R Fowkes; Richard Franklin; Marlene Fransen; Michael K Freeman; Belinda J Gabbe; Sherine E Gabriel; Emmanuela Gakidou; Hammad A Ganatra; Bianca Garcia; Flavio Gaspari; Richard F Gillum; Gerhard Gmel; Richard Gosselin; Rebecca Grainger; Justina Groeger; Francis Guillemin; David Gunnell; Ramyani Gupta; Juanita Haagsma; Holly Hagan; Yara A Halasa; Wayne Hall; Diana Haring; Josep Maria Haro; James E Harrison; Rasmus Havmoeller; Roderick J Hay; Hideki Higashi; Catherine Hill; Bruno Hoen; Howard Hoffman; Peter J Hotez; Damian Hoy; John J Huang; Sydney E Ibeanusi; Kathryn H Jacobsen; Spencer L James; Deborah Jarvis; Rashmi Jasrasaria; Sudha Jayaraman; Nicole Johns; Jost B Jonas; Ganesan Karthikeyan; Nicholas Kassebaum; Norito Kawakami; Andre Keren; Jon-Paul Khoo; Charles H King; Lisa Marie Knowlton; Olive Kobusingye; Adofo Koranteng; Rita Krishnamurthi; Ratilal Lalloo; Laura L Laslett; Tim Lathlean; Janet L Leasher; Yong Yi Lee; James Leigh; Stephen S Lim; Elizabeth Limb; John Kent Lin; Michael Lipnick; Steven E Lipshultz; Wei Liu; Maria Loane; Summer Lockett Ohno; Ronan Lyons; Jixiang Ma; Jacqueline Mabweijano; Michael F MacIntyre; Reza Malekzadeh; Leslie Mallinger; Sivabalan Manivannan; Wagner Marcenes; Lyn March; David J Margolis; Guy B Marks; Robin Marks; Akira Matsumori; Richard Matzopoulos; Bongani M Mayosi; John H McAnulty; Mary M McDermott; Neil McGill; John McGrath; Maria Elena Medina-Mora; Michele Meltzer; George A Mensah; Tony R Merriman; Ana-Claire Meyer; Valeria Miglioli; Matthew Miller; Ted R Miller; Philip B Mitchell; Ana Olga Mocumbi; Terrie E Moffitt; Ali A Mokdad; Lorenzo Monasta; Marcella Montico; Maziar Moradi-Lakeh; Andrew Moran; Lidia Morawska; Rintaro Mori; Michele E Murdoch; Michael K Mwaniki; Kovin Naidoo; M Nathan Nair; Luigi Naldi; K M Venkat Narayan; Paul K Nelson; Robert G Nelson; Michael C Nevitt; Charles R Newton; Sandra Nolte; Paul Norman; Rosana Norman; Martin O'Donnell; Simon O'Hanlon; Casey Olives; Saad B Omer; Katrina Ortblad; Richard Osborne; Doruk Ozgediz; Andrew Page; Bishnu Pahari; Jeyaraj Durai Pandian; Andrea Panozo Rivero; Scott B Patten; Neil Pearce; Rogelio Perez Padilla; Fernando Perez-Ruiz; Norberto Perico; Konrad Pesudovs; David Phillips; Michael R Phillips; Kelsey Pierce; Sébastien Pion; Guilherme V Polanczyk; Suzanne Polinder; C Arden Pope; Svetlana Popova; Esteban Porrini; Farshad Pourmalek; Martin Prince; Rachel L Pullan; Kapa D Ramaiah; Dharani Ranganathan; Homie Razavi; Mathilda Regan; Jürgen T Rehm; David B Rein; Guiseppe Remuzzi; Kathryn Richardson; Frederick P Rivara; Thomas Roberts; Carolyn Robinson; Felipe Rodriguez De Leòn; Luca Ronfani; Robin Room; Lisa C Rosenfeld; Lesley Rushton; Ralph L Sacco; Sukanta Saha; Uchechukwu Sampson; Lidia Sanchez-Riera; Ella Sanman; David C Schwebel; James Graham Scott; Maria Segui-Gomez; Saeid Shahraz; Donald S Shepard; Hwashin Shin; Rupak Shivakoti; David Singh; Gitanjali M Singh; Jasvinder A Singh; Jessica Singleton; David A Sleet; Karen Sliwa; Emma Smith; Jennifer L Smith; Nicolas J C Stapelberg; Andrew Steer; Timothy Steiner; Wilma A Stolk; Lars Jacob Stovner; Christopher Sudfeld; Sana Syed; Giorgio Tamburlini; Mohammad Tavakkoli; Hugh R Taylor; Jennifer A Taylor; William J Taylor; Bernadette Thomas; W Murray Thomson; George D Thurston; Imad M Tleyjeh; Marcello Tonelli; Jeffrey A Towbin; Thomas Truelsen; Miltiadis K Tsilimbaris; Clotilde Ubeda; Eduardo A Undurraga; Marieke J van der Werf; Jim van Os; Monica S Vavilala; N Venketasubramanian; Mengru Wang; Wenzhi Wang; Kerrianne Watt; David J Weatherall; Martin A Weinstock; Robert Weintraub; Marc G Weisskopf; Myrna M Weissman; Richard A White; Harvey Whiteford; Steven T Wiersma; James D Wilkinson; Hywel C Williams; Sean R M Williams; Emma Witt; Frederick Wolfe; Anthony D Woolf; Sarah Wulf; Pon-Hsiu Yeh; Anita K M Zaidi; Zhi-Jie Zheng; David Zonies; Alan D Lopez; Christopher J L Murray; Mohammad A AlMazroa; Ziad A Memish
Journal:  Lancet       Date:  2012-12-15       Impact factor: 79.321

View more
  3 in total

Review 1.  Migraine With Comorbid Depression: Pathogenesis, Clinical Implications, and Treatment.

Authors:  Nailah Asif; Apurva Patel; Deepanjali Vedantam; Devyani S Poman; Lakshya Motwani
Journal:  Cureus       Date:  2022-06-16

Review 2.  The exploration of mechanisms of comorbidity between migraine and depression.

Authors:  Qing Zhang; Anwen Shao; Zhengyan Jiang; Huitzong Tsai; Weibo Liu
Journal:  J Cell Mol Med       Date:  2019-05-20       Impact factor: 5.310

3.  High level of pattern glare in major depressive disorder.

Authors:  Xiongwei Qi; Huanhuan Fan; Xiao Yang; Yayun Chen; Wei Deng; Wanjun Guo; Qiang Wang; Eric Chen; Tao Li; Xiaohong Ma
Journal:  BMC Psychiatry       Date:  2019-12-21       Impact factor: 3.630

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.